An Open-Label, 3-Way Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of DS-8500a in Japanese Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 03 Jan 2017
At a glance
- Drugs DS-8500 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 22 Dec 2016 Status changed from active, no longer recruiting to completed.
- 25 Jul 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 22 Jun 2016 New trial record